Endosponge Vacuum Therapy (E-VAC) Registry of Intestinal Anastomotic Leaks and Perforations

Baylor Research Institute65 enrolled

Overview

The purpose of this registry is to collect data on the clinical use of endoluminal vacuum (E-Vac) therapy to treat both upper and lower intestinal leaks and perforations.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Intestinal Anastomotic Leak Intestinal Perforations

Interventions

No interventions are doneOTHER

No intervention is done. This is a registry study.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients undergoing E-Vac Therapy * Age \> 17 years Exclusion Criteria: * 17 years of age or younger * Undergone an E-Vac placement \> 14 days before consenting

Locations (1)

Baylor University Medical Center

Dallas, Texas, United States

Outcomes

Primary Outcomes

In-Hospital survival-rate

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.